Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 784.45

-0.4%

Nov 26 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (603)	12/18/2001 1:54:50 AM
From: Miljenko Zuanic	Read Replies (1) of 3559

jci.org J Clin Invest, December 2001, Volume 108, Number 12, 1729-1733 Copyright ©2001 by the American Society for Clinical Investigation -------------------------------------------------------------------------------- Perspective gp130 cytokine signaling in the pituitary gland: a paradigm for cytokine–neuro-endocrine pathways Eduardo Arzt1,2 1 Laboratorio de Fisiología y Biología Molecular, Facultad de Ciencias Exacias y Naturales, Universidad de Buenos Aires and Argentine National Research Council (CONICET), Buenos Aires, Argentina 2 Max-Planck-Institute of Psychiatry, Munich, Germany Address correspondence to: Eduardo Arzt, Laboratorio de Fisiología y Biología Molecular, Departamento de Biología, FCEN, Universidad de Buenos Aires, Ciudad Universitaria, Pabellon II, 1428 Buenos Aires, Argentina. Phone: 54-11-45763368; Fax: 54-11-45763321; E-mail: earzt@bg.fcen.uba.ar.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next